Close
Show

Press Releases

Press Releases is unique and effective promotional tool offered from Worldpharmatoday.com aimed at bringing our client’s business message into limelight and more importantly make it reach their target audience. This feature can be utilized to launch new product, promoting existing Pharma product, publish business agreements, annual reports, financial results, corporate performances, important announcements or any important information that has to be conveyed to the target audience.

Bristol-Myers Squibb Establishes Collaborative Immuno-Oncology Rare Population Malignancy (I-O RPM) Program in the U.S.


Company enters into a collaboration agreement with Robert H. Lurie Comprehensive Cancer Center of Northwestern...

Bristol-Myers Squibb and The Leukemia & Lymphoma Society Announce Charitable Donation to Support Critical...


"With the life expectancy of more CML patients increasing, the need for routine PCR testing...

Pall Purchases Exclusive License to Cutting-Edge Acoustic Wave Separation Technology from FloDesign Sonics for...


Pall Corporation, a global leader in filtration, separation and purification, announced the signing of an...

Venturing into chemicals in France


Invest in Grenoble-Isère and Rhône Valley - ACHEMA 2015 Hall 9.2, stand D41 Adisseo, Hexcel,...

ThyssenKrupp Uhde Chlorine Engineers and McPhy Energy seal a strategic commercial alliance in the...


McPhy Energy to become ThyssenKrupp Uhde Chlorine Engineers’ exclusive supplier for high-capacity, high-pressure hydrogen generation...

AMPO FOUNDRY OFFERS HIGH-ADDED-VALUE VALVE, PUMP & POWER GENERATION COMPONENTS


AMPO, a leading foundry specialising in stainless steel and high alloy castings, with over 50...

At Pack/Pharma Expo, DIR Technologies to Debut “Lite” Version of Thermal Image-driven Induction...


Viable for Non-Pharma Sectors such as Food and Cosmetics, New Simplified System Provides Induction...

Bristol-Myers Squibb to Present Data from 14 Abstracts on Orencia (abatacept) at the European...


Bristol-Myers Squibb Company (NYSE:BMY) announced that 14 abstracts on Orencia have been accepted for presentation...

Adding Investigational Agent Elotuzumab to Standard Treatment for Multiple Myeloma Significantly Reduced the Risk...


Bristol-Myers Squibb Company (NYSE:BMY) and AbbVie (NYSE:ABBV) today announced that results from an interim analysis...

Bristol-Myers Squibb to Take Part in Goldman Sachs 36th Annual Global Health Care Conference


Bristol-Myers Squibb Company (NYSE:BMY) will take part in Goldman Sachs 36th Annual Global Health Care...